273 related articles for article (PubMed ID: 33526631)
1. Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.
Zhang L; Shi J; Pan Y; Li Z; Yan H; Liu C; Lv W; Meng X; Wang Y
Stroke Vasc Neurol; 2021 Sep; 6(3):376-383. PubMed ID: 33526631
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China.
Wang Y; Jing J; Pan Y; Wang M; Meng X; Wang Y
Ann Palliat Med; 2022 Jul; 11(7):2215-2224. PubMed ID: 35272470
[TBL] [Abstract][Full Text] [Related]
3. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.
Ji R; Liu G; Shen H; Wang Y; Li H; Peterson E; Wang Y
Neurol Res; 2013 Jan; 35(1):29-36. PubMed ID: 23317796
[TBL] [Abstract][Full Text] [Related]
4. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol.
Boehme C; Domig L; Komarek S; Toell T; Mayer L; Dejakum B; Krebs S; Pechlaner R; Bernegger A; Mueller C; Rumpold G; Griesmacher A; Vigl M; Schoenherr G; Schmidauer C; Ferrari J; Lang W; Knoflach M; Kiechl S
BMC Cardiovasc Disord; 2022 Aug; 22(1):347. PubMed ID: 35915405
[TBL] [Abstract][Full Text] [Related]
6. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
7. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
Hobeanu C; Lavallée PC; Charles H; Labreuche J; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Molina CA; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut E; Wong KSL; Amarenco P;
Lancet Neurol; 2022 Oct; 21(10):889-898. PubMed ID: 36115361
[TBL] [Abstract][Full Text] [Related]
8. LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA.
Pan Y; Wangqin R; Li H; Jin A; Li J; Lin J; Meng X; Xian Y; Laskowitz DT; Wang Y
Stroke Vasc Neurol; 2022 Aug; 7(4):276-284. PubMed ID: 35256525
[TBL] [Abstract][Full Text] [Related]
9. One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry.
Tan Y; Pan Y; Liu L; Wang Y; Zhao X; Wang Y;
Neurol Res; 2017 Jun; 39(6):484-491. PubMed ID: 28476094
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
[TBL] [Abstract][Full Text] [Related]
11. Precision antiplatelet therapy for the prevention of ischaemic stroke.
Wang D
Stroke Vasc Neurol; 2022 Apr; 7(2):89-91. PubMed ID: 34716284
[No Abstract] [Full Text] [Related]
12. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
[TBL] [Abstract][Full Text] [Related]
14. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
[TBL] [Abstract][Full Text] [Related]
15. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670
[TBL] [Abstract][Full Text] [Related]
17. Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China, 2007-2018: insights from China National Stroke Registries.
Li L; Pan Y; Wang M; Jing J; Meng X; Jiang Y; Guo C; Jin Z; Wang Y
Stroke Vasc Neurol; 2021 Jun; 6(2):214-221. PubMed ID: 33127855
[TBL] [Abstract][Full Text] [Related]
18. CO
Wang A; Tian X; Gu H; Zuo Y; Meng X; Lv W; Li H; Wang Y
Stroke Vasc Neurol; 2021 Jun; 6(2):252-259. PubMed ID: 33298534
[TBL] [Abstract][Full Text] [Related]
19. Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol.
Toell T; Boehme C; Mayer L; Krebs S; Lang C; Willeit K; Prantl B; Knoflach M; Rumpold G; Schoenherr G; Griesmacher A; Willeit P; Ferrari J; Lang W; Kiechl S; Willeit J
BMC Neurol; 2018 Nov; 18(1):187. PubMed ID: 30400876
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
